US2056046A
(en)
*
|
1933-05-19 |
1936-09-29 |
Rhone Poulenc Sa |
Manufacture of bases derived from benz-dioxane
|
US2375138A
(en)
*
|
1942-05-01 |
1945-05-01 |
American Cyanamid Co |
Alkamine esters of aryloxymethyl benzoic acid
|
US2629736A
(en)
*
|
1951-02-24 |
1953-02-24 |
Searle & Co |
Basically substituted n-alkyl derivatives of alpha, beta, beta-triarylpropionamides
|
US2730544A
(en)
*
|
1952-07-23 |
1956-01-10 |
Sahyun Lab |
Alkylaminoalkyl esters of hydroxycyclohexylbenzoic acid
|
US2750387A
(en)
*
|
1953-11-25 |
1956-06-12 |
Searle & Co |
Basically substituted derivatives of diarylaminobenzamides
|
DE1211359B
(de)
*
|
1955-11-29 |
1966-02-24 |
Oreal |
Oxydationsmittelfreies Kaltfaerbemittel fuer menschliches Haar
|
US2928833A
(en)
*
|
1959-03-03 |
1960-03-15 |
S E Massengill Company |
Theophylline derivatives
|
US3174901A
(en)
*
|
1963-01-31 |
1965-03-23 |
Jan Marcel Didier Aron Samuel |
Process for the oral treatment of diabetes
|
US3454635A
(en)
*
|
1965-07-27 |
1969-07-08 |
Hoechst Ag |
Benzenesulfonyl-ureas and process for their manufacture
|
US3673241A
(en)
*
|
1968-04-04 |
1972-06-27 |
Ciba Geigy Corp |
Substituted benzaldehyde guanylhydrazones
|
ES385302A1
(es)
|
1970-10-22 |
1973-04-16 |
Miquel S A Lab |
Procedimiento para la obtencion de derivados trisubstitui- dos de etilendiamina.
|
DE2205815A1
(de)
|
1972-02-08 |
1973-08-16 |
Hoechst Ag |
Piperazinderivate und verfahren zu ihrer herstellung
|
JPS5512435B2
(es)
*
|
1972-07-01 |
1980-04-02 |
|
|
US4005208A
(en)
*
|
1975-05-16 |
1977-01-25 |
Smithkline Corporation |
N-Heterocyclic-9-xanthenylamines
|
US4061753A
(en)
*
|
1976-02-06 |
1977-12-06 |
Interx Research Corporation |
Treating psoriasis with transient pro-drug forms of xanthine derivatives
|
AU508480B2
(en)
|
1977-04-13 |
1980-03-20 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
|
DE2758025A1
(de)
|
1977-12-24 |
1979-07-12 |
Bayer Ag |
Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
DE2904885A1
(de)
|
1979-02-09 |
1980-08-14 |
Rothenberger Gmbh Co |
Biegevorrichtung fuer metallrohre
|
DE2929596A1
(de)
|
1979-07-21 |
1981-02-05 |
Hoechst Ag |
Verfahren zur herstellung von oxoalkyl-xanthinen
|
GB2084580B
(en)
|
1980-10-01 |
1984-07-04 |
Glaxo Group Ltd |
Aminoalkyl furan derivative
|
US4382091A
(en)
|
1981-04-30 |
1983-05-03 |
Syntex (U.S.A.) Inc. |
Stabilization of 1-substituted imidazole derivatives in talc
|
FR2558162B1
(fr)
*
|
1984-01-17 |
1986-04-25 |
Adir |
Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
|
FI79107C
(fi)
*
|
1984-06-25 |
1989-11-10 |
Orion Yhtymae Oy |
Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
|
JPS6130567A
(ja)
|
1984-07-23 |
1986-02-12 |
Shiseido Co Ltd |
尿素の安定化法
|
JPS61124383A
(ja)
|
1984-11-16 |
1986-06-12 |
Unitika Ltd |
固定化線維素溶解活性酵素の安定化法
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
CA1242699A
(en)
|
1985-02-01 |
1988-10-04 |
Bristol-Myers Company |
Cefbuperazone and derivatives thereof
|
US4741898A
(en)
|
1985-04-01 |
1988-05-03 |
Fisher Scientific Company |
Stabilized stain composition
|
US5258380A
(en)
*
|
1985-06-24 |
1993-11-02 |
Janssen Pharmaceutica N.V. |
(4-piperidinylmethyl and -hetero)purines
|
GB8515934D0
(en)
*
|
1985-06-24 |
1985-07-24 |
Janssen Pharmaceutica Nv |
(4-piperidinomethyl and-hetero)purines
|
EP0223403B1
(en)
|
1985-10-25 |
1993-08-04 |
Beecham Group Plc |
Piperidine derivative, its preparation, and its use as medicament
|
US5034225A
(en)
|
1985-12-17 |
1991-07-23 |
Genentech Inc. |
Stabilized human tissue plasminogen activator compositions
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
EP0237608B1
(de)
|
1986-03-21 |
1992-01-29 |
HEUMANN PHARMA GMBH & CO |
Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
|
EP0587255A1
(en)
|
1986-05-05 |
1994-03-16 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
AU619444B2
(en)
|
1986-06-02 |
1992-01-30 |
Nippon Chemiphar Co. Ltd. |
2-(2-aminobenzylsulfinyl)- benzimidazole derivatives
|
US4968672A
(en)
*
|
1987-01-02 |
1990-11-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adenosine receptor prodrugs
|
US4743450A
(en)
|
1987-02-24 |
1988-05-10 |
Warner-Lambert Company |
Stabilized compositions
|
US5093330A
(en)
|
1987-06-15 |
1992-03-03 |
Ciba-Geigy Corporation |
Staurosporine derivatives substituted at methylamino nitrogen
|
JPS6440433A
(en)
|
1987-08-05 |
1989-02-10 |
Green Cross Corp |
Aqueous liquid composition of thrombin
|
ES2070142T3
(es)
|
1988-05-19 |
1995-06-01 |
Chugai Pharmaceutical Co Ltd |
Nuevos derivados del acido quinolonacarboxilico.
|
US5329025A
(en)
*
|
1988-09-21 |
1994-07-12 |
G. D. Searle & Co. |
3-azido compound
|
DE3926119A1
(de)
|
1989-08-08 |
1991-02-14 |
Bayer Ag |
3-amino-5-aminocarbonyl-1,2,4-triazol-derivate
|
US5234897A
(en)
*
|
1989-03-15 |
1993-08-10 |
Bayer Aktiengesellschaft |
Herbicidal 3-amino-5-aminocarbonyl-1,2,4-triazoles
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
DE3916430A1
(de)
*
|
1989-05-20 |
1990-11-22 |
Bayer Ag |
Verfahren zur herstellung von 3-amino-5-aminocarbonyl-1,2,4-triazol-derivaten
|
IL94390A
(en)
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
|
US5332744A
(en)
*
|
1989-05-30 |
1994-07-26 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
US5223499A
(en)
*
|
1989-05-30 |
1993-06-29 |
Merck & Co., Inc. |
6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
|
FI94339C
(fi)
*
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
HU208115B
(en)
|
1989-10-03 |
1993-08-30 |
Biochemie Gmbh |
New process for producting pleuromutilin derivatives
|
FR2654935B1
(fr)
|
1989-11-28 |
1994-07-01 |
Lvmh Rech |
Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux.
|
CN1020944C
(zh)
|
1990-01-30 |
1993-05-26 |
阿图尔-费希尔股份公司费希尔厂 |
紧固件
|
DE19675036I2
(de)
*
|
1990-02-19 |
2004-10-21 |
Novartis Ag |
Acylverbindungen.
|
KR930000861B1
(ko)
*
|
1990-02-27 |
1993-02-08 |
한미약품공업 주식회사 |
오메프라졸 직장투여 조성물
|
DE69104453T2
(de)
|
1990-09-13 |
1995-03-16 |
Akzo Nv |
Stabilisierte feste chemische Zusammensetzungen.
|
GB9020959D0
(en)
|
1990-09-26 |
1990-11-07 |
Beecham Group Plc |
Novel compounds
|
US5084460A
(en)
*
|
1990-12-24 |
1992-01-28 |
A. H. Robins Company, Incorporated |
Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
|
US5594003A
(en)
|
1991-02-06 |
1997-01-14 |
Dr. Karl Thomae Gmbh |
Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
|
US5602127A
(en)
*
|
1991-02-06 |
1997-02-11 |
Karl Thomae Gmbh |
(Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
|
US5614519A
(en)
|
1991-02-06 |
1997-03-25 |
Karl Thomae Gmbh |
(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
|
GB9109862D0
(en)
|
1991-05-08 |
1991-07-03 |
Beecham Lab Sa |
Pharmaceutical formulations
|
DE4124150A1
(de)
*
|
1991-07-20 |
1993-01-21 |
Bayer Ag |
Substituierte triazole
|
TW225528B
(es)
|
1992-04-03 |
1994-06-21 |
Ciba Geigy Ag |
|
US5300298A
(en)
*
|
1992-05-06 |
1994-04-05 |
The Pennsylvania Research Corporation |
Methods of treating obesity with purine related compounds
|
GB9215633D0
(en)
|
1992-07-23 |
1992-09-09 |
Smithkline Beecham Plc |
Novel treatment
|
ATE165360T1
(de)
*
|
1992-07-31 |
1998-05-15 |
Shionogi & Co |
Triazolylthiomethylthiocephalosporin- hydrochlorid, sein kristallines hydrat und seine herstellung
|
TW252044B
(es)
|
1992-08-10 |
1995-07-21 |
Boehringer Ingelheim Kg |
|
US5358941A
(en)
|
1992-12-02 |
1994-10-25 |
Merck & Co., Inc. |
Dry mix formulation for bisphosphonic acids with lactose
|
DE4242459A1
(de)
*
|
1992-12-16 |
1994-06-23 |
Merck Patent Gmbh |
Imidazopyridine
|
AU6087894A
(en)
|
1993-01-14 |
1994-08-15 |
Cell Therapeutics, Inc. |
Acetal or ketal substituted therapeutic compounds
|
US5624926A
(en)
|
1993-02-18 |
1997-04-29 |
Kyowa Hakko Kogyo Co., Ltd. |
Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors
|
JP3726291B2
(ja)
|
1993-07-05 |
2005-12-14 |
三菱ウェルファーマ株式会社 |
安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
|
FR2707641B1
(fr)
|
1993-07-16 |
1995-08-25 |
Fournier Ind & Sante |
Composés de l'imidazol-5-carboxamide, leur procédé de préparation leurs intermédiaires et leur utilisation en thérapeutique.
|
DE4339868A1
(de)
|
1993-11-23 |
1995-05-24 |
Merck Patent Gmbh |
Imidazopyridazine
|
DE4404183A1
(de)
|
1994-02-10 |
1995-08-17 |
Merck Patent Gmbh |
4-Amino-1-piperidylbenzoylguanidine
|
US5545745A
(en)
|
1994-05-23 |
1996-08-13 |
Sepracor, Inc. |
Enantioselective preparation of optically pure albuterol
|
CO4410191A1
(es)
|
1994-09-19 |
1997-01-09 |
Lilly Co Eli |
SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
|
WO1996011917A1
(en)
|
1994-10-12 |
1996-04-25 |
Euro-Celtique, S.A. |
Novel benzoxazoles
|
GB9501178D0
(en)
*
|
1995-01-20 |
1995-03-08 |
Wellcome Found |
Guanine derivative
|
US5821366A
(en)
|
1995-05-19 |
1998-10-13 |
Chiroscience Limited |
Xanthines and their therapeutic use
|
DK0832066T3
(da)
|
1995-06-06 |
2001-11-19 |
Pfizer |
Substituerede N-(indol-2-carbonyl)amider og derivater som glycogenphosphorylaseinhibitorer
|
WO1996039384A1
(en)
|
1995-06-06 |
1996-12-12 |
Pfizer, Inc. |
Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
|
JPH08333339A
(ja)
|
1995-06-08 |
1996-12-17 |
Fujisawa Pharmaceut Co Ltd |
光学活性なピペリジン酢酸誘導体の製造法
|
GB9523752D0
(en)
|
1995-11-21 |
1996-01-24 |
Pfizer Ltd |
Pharmaceutical formulations
|
DE19543478A1
(de)
|
1995-11-22 |
1997-05-28 |
Bayer Ag |
Kristallines Hydrochlorid von {(R)-(-)-2- N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-buytl]-aminomethyl}-chroman
|
FR2742751B1
(fr)
|
1995-12-22 |
1998-01-30 |
Rhone Poulenc Rorer Sa |
Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
|
PT888293E
(pt)
|
1995-12-26 |
2002-07-31 |
Alteon Inc |
N-acilaminoalquilhidrazinocarboximidamidas
|
US5891855A
(en)
*
|
1996-02-12 |
1999-04-06 |
The Scripps Research Institute |
Inhibitors of leaderless protein export
|
DE19616486C5
(de)
*
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
TW518219B
(en)
|
1996-04-26 |
2003-01-21 |
Chugai Pharmaceutical Co Ltd |
Erythropoietin solution preparation
|
WO1997046526A1
(en)
|
1996-06-07 |
1997-12-11 |
Eisai Co., Ltd. |
Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
|
US5965555A
(en)
*
|
1996-06-07 |
1999-10-12 |
Hoechst Aktiengesellschaft |
Xanthine compounds having terminally animated alkynol side chains
|
US5958951A
(en)
*
|
1996-06-14 |
1999-09-28 |
Novo Nordiskials |
Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
|
US5753635A
(en)
|
1996-08-16 |
1998-05-19 |
Berlex Laboratories, Inc. |
Purine derivatives and their use as anti-coagulants
|
WO1998011893A1
(en)
|
1996-09-23 |
1998-03-26 |
Eli Lilly And Company |
Olanzapine dihydrate d
|
EP0937056A1
(en)
|
1996-10-28 |
1999-08-25 |
Novo Nordisk A/S |
A process for the preparation of (-)-3,4-trans-diarylchromans
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
ATE366584T1
(de)
|
1996-11-12 |
2007-08-15 |
Novo Nordisk As |
Verwendung von glp-1 peptiden
|
GB9623859D0
(en)
|
1996-11-15 |
1997-01-08 |
Chiroscience Ltd |
Novel compounds
|
PT948358E
(pt)
|
1996-12-24 |
2004-10-29 |
Biogen Idec Inc |
Formulacoes de interferao liquidas e estaveis
|
DE19705233A1
(de)
|
1997-02-12 |
1998-08-13 |
Froelich Juergen C |
Verfahren zur Herstellung einer Formulierung enthaltend Arginin
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
US6011049A
(en)
|
1997-02-19 |
2000-01-04 |
Warner-Lambert Company |
Combinations for diabetes
|
ZA982155B
(en)
|
1997-03-13 |
1998-12-01 |
Hexal Ag |
Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
|
US5972332A
(en)
|
1997-04-16 |
1999-10-26 |
The Regents Of The University Of Michigan |
Wound treatment with keratinocytes on a solid support enclosed in a porous material
|
PE79099A1
(es)
|
1997-06-13 |
1999-08-24 |
Lilly Co Eli |
Formulaciones de insulina estables
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
EE200000318A
(et)
*
|
1997-12-05 |
2001-08-15 |
Astrazeneca Uk Limited |
Uudsed ühendid
|
ID21411A
(id)
|
1997-12-10 |
1999-06-10 |
Takeda Chemical Industries Ltd |
Agen untuk mengobati daya tahan glukosa yang berisiko tinggi rusak
|
JPH11193270A
(ja)
|
1997-12-26 |
1999-07-21 |
Koei Chem Co Ltd |
光学活性1−メチル−3−ピペリジンメタノールの製造方法
|
DE69815554T2
(de)
|
1998-01-05 |
2004-05-06 |
Eisai Co., Ltd. |
Purinderivate und antagonisten des adenosin-a2-rezeptors, welche zur vorsorge oder heilung von diabetes dienen
|
EP2574336A1
(en)
|
1998-02-02 |
2013-04-03 |
Trustees Of Tufts College |
Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
|
US5998463A
(en)
|
1998-02-27 |
1999-12-07 |
Pfizer Inc |
Glycogen phosphorylase inhibitors
|
US20030013740A1
(en)
|
1998-03-27 |
2003-01-16 |
Martin P. Redmon |
Stable dosage forms of fluoxetine and its enantiomers
|
IL138521A0
(en)
|
1998-03-31 |
2001-10-31 |
Nissan Chemical Ind Ltd |
Pyridazinone hydrochloride compound and method for producing the same
|
CA2268621A1
(en)
|
1998-04-13 |
1999-10-13 |
Takeda Chemical Industries, Ltd. |
2-pipirazinone-1-acetic acid derivative, production and use thereof
|
US6207207B1
(en)
|
1998-05-01 |
2001-03-27 |
Mars, Incorporated |
Coated confectionery having a crispy starch based center and method of preparation
|
DE19823831A1
(de)
*
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
WO2000003735A1
(fr)
|
1998-07-15 |
2000-01-27 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Excipient
|
EP0978279A1
(en)
|
1998-08-07 |
2000-02-09 |
Pfizer Products Inc. |
Inhibitors of human glycogen phosphorylase
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
IT1312018B1
(it)
*
|
1999-03-19 |
2002-04-04 |
Fassi Aldo |
Procedimento migliorato per la produzione di sali non igroscopicidella l(-)-carnitina.
|
CA2368347C
(en)
|
1999-03-29 |
2007-05-22 |
F. Hoffmann-La Roche Ag |
Glucokinase activators
|
WO2000066101A2
(en)
|
1999-04-30 |
2000-11-09 |
City Of Hope |
Method of inhibiting glycation product formation
|
US20040152659A1
(en)
|
1999-05-12 |
2004-08-05 |
Fujisawa Pharmaceutical Co. Ltd. |
Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
|
AU4431000A
(en)
|
1999-05-12 |
2000-12-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel use
|
AU5294100A
(en)
|
1999-05-27 |
2000-12-18 |
University Of Virginia Patent Foundation |
Method and compositions for treating the inflammatory response
|
EP1180368B1
(en)
|
1999-05-31 |
2007-04-18 |
Mitsubishi Chemical Corporation |
Freeze dried hgf preparations
|
EP1185371B2
(en)
|
1999-06-01 |
2008-11-12 |
Elan Pharma International Limited |
Small-scale mill and method thereof
|
US6545002B1
(en)
|
1999-06-01 |
2003-04-08 |
University Of Virginia Patent Foundation |
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
|
UA71976C2
(en)
|
1999-06-21 |
2005-01-17 |
Boehringer Ingelheim Pharma |
Bicyclic heterocycles and a medicament based thereon
|
US6448323B1
(en)
|
1999-07-09 |
2002-09-10 |
Bpsi Holdings, Inc. |
Film coatings and film coating compositions based on polyvinyl alcohol
|
ES2166270B1
(es)
|
1999-07-27 |
2003-04-01 |
Almirall Prodesfarma Sa |
Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
|
KR100591585B1
(ko)
|
1999-08-31 |
2006-06-20 |
깃세이 야쿠힌 고교 가부시키가이샤 |
글루코피라노실옥시피라졸 유도체, 그것을 함유하는 의약조성물 및 그 제조 중간체
|
EP1220832A1
(en)
|
1999-09-29 |
2002-07-10 |
Novo Nordisk A/S |
Novel aromatic compounds
|
EP1391460A1
(en)
|
1999-09-30 |
2004-02-25 |
Pfizer Products Inc. |
Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
EP1088824B1
(en)
|
1999-09-30 |
2004-01-07 |
Pfizer Products Inc. |
Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
US6353111B1
(en)
|
1999-12-15 |
2002-03-05 |
Hoffmann-La Roche Inc. |
Trans olefinic glucokinase activators
|
CA2393083C
(en)
|
1999-12-23 |
2010-01-26 |
Novartis Ag |
Use of hypoglycemic agent for treating impaired glucose metabolism
|
MXPA02006660A
(es)
|
2000-01-07 |
2002-12-13 |
Transform Pharmaceuticals Inc |
Formacion, identificacion y analisis de diversas formas solidas de alto rendimiento.
|
US6362172B2
(en)
|
2000-01-20 |
2002-03-26 |
Bristol-Myers Squibb Company |
Water soluble prodrugs of azole compounds
|
JP2003520226A
(ja)
|
2000-01-21 |
2003-07-02 |
ノバルティス アクチエンゲゼルシャフト |
ジペプチジルペプチダーゼ−iv阻害剤および抗糖尿病薬剤を含む組合せ物
|
CO5271699A1
(es)
|
2000-01-24 |
2003-04-30 |
Pfizer Prod Inc |
Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
|
JP4621326B2
(ja)
|
2000-02-01 |
2011-01-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
テプレノンの安定化組成物
|
WO2001056993A2
(en)
*
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
WO2001062295A1
(fr)
|
2000-02-24 |
2001-08-30 |
Takeda Chemical Industries, Ltd. |
Medicaments contenant des ingredients actifs combines
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
GB0006133D0
(en)
|
2000-03-14 |
2000-05-03 |
Smithkline Beecham Plc |
Novel pharmaceutical
|
RU2254340C2
(ru)
|
2000-03-17 |
2005-06-20 |
Киссеи Фармасьютикал Ко., Лтд. |
Глюкопиранозилоксибензилбензольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для получения указанных производных
|
EP1136071A3
(en)
|
2000-03-22 |
2003-03-26 |
Pfizer Products Inc. |
Use of glycogen phosphorylase inhibitors
|
JP2001278812A
(ja)
|
2000-03-27 |
2001-10-10 |
Kyoto Pharmaceutical Industries Ltd |
錠剤用崩壊剤及びこれを用いた錠剤
|
US6555519B2
(en)
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
US6683056B2
(en)
|
2000-03-30 |
2004-01-27 |
Bristol-Myers Squibb Company |
O-aryl glucoside SGLT2 inhibitors and method
|
US6399101B1
(en)
|
2000-03-30 |
2002-06-04 |
Mova Pharmaceutical Corp. |
Stable thyroid hormone preparations and method of making same
|
EP1273306A4
(en)
|
2000-03-31 |
2005-06-22 |
Kirin Brewery |
POWDER PREPARATION INTENDED FOR MUCOUS MEMBRANES COMPRISING A POLYMERIC MEDICAMENT HAVING IMPROVED STORAGE STABILITY
|
ATE419036T1
(de)
*
|
2000-03-31 |
2009-01-15 |
Prosidion Ltd |
Verbesserung der aktivität der inselzellen bei diabetes mellitus und dessen prävention
|
JP2001292388A
(ja)
|
2000-04-05 |
2001-10-19 |
Sharp Corp |
再生装置
|
GB0008694D0
(en)
|
2000-04-07 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
DE60113247T2
(de)
|
2000-05-03 |
2006-06-22 |
F. Hoffmann-La Roche Ag |
Hydantoin-enthaltende glucokinase aktivatoren
|
EP1282612B1
(en)
|
2000-05-03 |
2004-12-29 |
F. Hoffmann-La Roche Ag |
Alkynyl phenyl heteroaromatic glucokinase activators
|
MXPA02010796A
(es)
|
2000-05-08 |
2003-03-27 |
Hoffmann La Roche |
Fenilacetamidas sustituidas y sus usos como activadores de glucocinasa.
|
CA2407763C
(en)
|
2000-05-08 |
2007-04-24 |
Fred Thomas Bizzarro |
Para-amine substituted phenylamide glucokinase activators
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
TR200401029T4
(tr)
|
2000-06-09 |
2004-06-21 |
Aventis Pharma Deutschland Gmbh |
Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
|
US6962998B2
(en)
|
2000-06-14 |
2005-11-08 |
Toray Industries, Inc. |
Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
US6689353B1
(en)
|
2000-06-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Stabilized interleukin 2
|
AU2001268958B2
(en)
*
|
2000-07-04 |
2006-03-09 |
Novo Nordisk A/S |
Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
|
WO2002008209A1
(en)
|
2000-07-20 |
2002-01-31 |
F. Hoffmann-La Roche Ag |
Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
|
EP1950199B1
(en)
*
|
2000-08-10 |
2009-12-02 |
Mitsubishi Tanabe Pharma Corporation |
Proline derivatives and use thereof as drugs
|
US6369232B1
(en)
|
2000-08-15 |
2002-04-09 |
Hoffmann-La Roche Inc. |
Tetrazolyl-phenyl acetamide glucokinase activators
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
US6821978B2
(en)
|
2000-09-19 |
2004-11-23 |
Schering Corporation |
Xanthine phosphodiesterase V inhibitors
|
KR100647204B1
(ko)
|
2000-09-29 |
2006-11-17 |
깃세이 야쿠힌 고교 가부시키가이샤 |
글루코피라노실옥시벤질벤젠 유도체 및 그것을 함유하는의약조성물
|
EP1338603B1
(en)
|
2000-11-02 |
2010-01-20 |
Ajinomoto Co., Inc. |
Novel pyrazole derivatives and diabetes remedies containing the same
|
US20060034922A1
(en)
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6722883B2
(en)
|
2000-11-13 |
2004-04-20 |
G & H Technologies Llc |
Protective coating for abrasive dental tools and burs
|
AU2002223127A1
(en)
|
2000-11-30 |
2002-06-11 |
Kissei Pharmaceutical Co., Ltd. Intellectual Property |
Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
|
DK1341774T3
(da)
|
2000-12-06 |
2006-06-12 |
Hoffmann La Roche |
Kondenserede heteroaromatiske glucokinase-aktivatorer
|
US6821261B2
(en)
|
2000-12-12 |
2004-11-23 |
Dj Orthopedics, Llc |
Orthopedic brace having length-adjustable supports
|
US6482951B2
(en)
|
2000-12-13 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Isoindolin-1-one glucokinase activators
|
US20040180925A1
(en)
|
2000-12-27 |
2004-09-16 |
Kenji Matsuno |
Dipeptidylpeptidase-IV inhibitor
|
SK287786B6
(sk)
|
2000-12-28 |
2011-09-05 |
Kissei Pharmaceutical Co., Ltd. |
Glukopyranosyloxypyrazolový derivát, farmaceutická kompozícia alebo kombinácia s jeho obsahom a ich použitie
|
FR2818906B1
(fr)
|
2000-12-29 |
2004-04-02 |
Dospharma |
Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
|
FR2819254B1
(fr)
|
2001-01-08 |
2003-04-18 |
Fournier Lab Sa |
Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques
|
DE10117803A1
(de)
|
2001-04-10 |
2002-10-24 |
Boehringer Ingelheim Pharma |
Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
DE10109021A1
(de)
|
2001-02-24 |
2002-09-05 |
Boehringer Ingelheim Pharma |
Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
CZ20032321A3
(en)
|
2001-02-02 |
2004-03-17 |
Takeda Chemical Industries, Ltd. |
Fused heterocyclic compounds
|
TWI255817B
(en)
|
2001-02-14 |
2006-06-01 |
Kissei Pharmaceutical |
Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
|
US6649187B2
(en)
|
2001-02-16 |
2003-11-18 |
Bristol-Myers Squibb Pharma Company |
Use of polyalkylamine polymers in controlled release devices
|
US6610326B2
(en)
|
2001-02-16 |
2003-08-26 |
Andrx Corporation |
Divalproex sodium tablets
|
PT1953162E
(pt)
|
2001-02-24 |
2012-07-13 |
Boehringer Ingelheim Pharma |
Derivados de xantina, sua preparação e sua utilização como produto farmacêutico
|
CA2438593C
(en)
|
2001-02-26 |
2010-09-21 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivatives and medicinal use thereof
|
DE60237580D1
(de)
|
2001-02-27 |
2010-10-21 |
Kissei Pharmaceutical |
Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
|
US6936590B2
(en)
|
2001-03-13 |
2005-08-30 |
Bristol Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
US6693094B2
(en)
|
2001-03-22 |
2004-02-17 |
Chrono Rx Llc |
Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
|
GB0107383D0
(en)
|
2001-03-23 |
2001-05-16 |
Univ Edinburgh |
Lipid profile modulation
|
DK1385856T3
(da)
|
2001-04-11 |
2006-05-15 |
Bristol Myers Squibb Co |
Aminosyrekomplekser af C-aryl-glucosider til behandling af diabetes og fremgangsmåder
|
EP1389621A4
(en)
|
2001-04-27 |
2005-05-11 |
Ajinomoto Kk |
N-SUBSTITUTED PYRAZOLYL-O-GLYCOSIDE DERIVATIVES AND DIABETES CONTAINING THEREOF
|
JP2002348279A
(ja)
|
2001-05-25 |
2002-12-04 |
Nippon Kayaku Co Ltd |
光学活性ピリジルケトン誘導体の製造方法並びに光学活性ピリジルケトン誘導体
|
PE20021091A1
(es)
|
2001-05-25 |
2003-02-04 |
Aventis Pharma Gmbh |
Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
|
US7217697B2
(en)
|
2001-05-30 |
2007-05-15 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor
|
CN100376592C
(zh)
|
2001-06-20 |
2008-03-26 |
橘生药品工业株式会社 |
含氮的杂环衍生物、含有该衍生物的药物组合物、其药物应用以及用于该衍生物制备的中间体
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
US6901589B2
(en)
*
|
2001-06-25 |
2005-05-31 |
Wind River Systems, Inc. |
System and method for determining a root cause of a failure
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
SE0102300D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
WO2003002553A2
(en)
|
2001-06-27 |
2003-01-09 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
CN1990469A
(zh)
|
2001-06-27 |
2007-07-04 |
史密丝克莱恩比彻姆公司 |
作为二肽酶抑制剂的氟代吡咯烷
|
JP4115105B2
(ja)
|
2001-07-02 |
2008-07-09 |
協和醗酵工業株式会社 |
ピラゾール誘導体
|
US6869947B2
(en)
*
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
ATE388951T1
(de)
|
2001-07-03 |
2008-03-15 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
MXPA04000224A
(es)
|
2001-07-10 |
2005-07-25 |
4Sc Ag |
Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos.
|
JPWO2003011880A1
(ja)
|
2001-07-31 |
2004-11-18 |
キッセイ薬品工業株式会社 |
グルコピラノシルオキシベンジルベンゼン誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
|
US7638522B2
(en)
|
2001-08-13 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
|
AR035119A1
(es)
|
2001-08-16 |
2004-04-14 |
Lilly Co Eli |
Anticuerpos humanos antagonistas anti-htnfsf13b
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
US20030087843A1
(en)
|
2001-09-05 |
2003-05-08 |
Washburn William N. |
O-pyrazole glucoside SGLT2 inhibitors and method of use
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
EP1463727A2
(en)
|
2001-09-19 |
2004-10-06 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
EP1585956A4
(en)
|
2001-09-24 |
2009-10-21 |
Univ Oregon Health & Science |
EVALUATIONS OF NEURONS IN THE ARQUE CORE FOR THE SCREENING OF AGENTS OF MODIFICATION OF FOOD BEHAVIOR
|
DE10294792D2
(de)
|
2001-10-15 |
2004-09-16 |
Hemoteq Gmbh |
Beschichtung von Stents zur Verhinderung von Restenose
|
DE10151296A1
(de)
|
2001-10-17 |
2003-04-30 |
Boehringer Ingelheim Pharma |
Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
US20030083354A1
(en)
|
2001-10-26 |
2003-05-01 |
Pediamed Pharmaceuticals, Inc. |
Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
|
JPWO2003037864A1
(ja)
|
2001-10-29 |
2005-02-17 |
日本たばこ産業株式会社 |
インドール化合物及びその医薬用途
|
EP1470246A2
(en)
*
|
2001-10-31 |
2004-10-27 |
Novartis AG |
Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
|
CA2363053C
(en)
|
2001-11-09 |
2011-01-25 |
Bernard Charles Sherman |
Clopidogrel bisulfate tablet formulation
|
AU2002353717B2
(en)
|
2001-11-22 |
2006-08-03 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
AU2002353716A1
(en)
|
2001-11-22 |
2003-06-10 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
BR0214343A
(pt)
|
2001-11-22 |
2004-09-14 |
Biovitrum Ab |
Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
|
EP2769715A3
(en)
|
2001-11-26 |
2014-09-17 |
Trustees Of Tufts College |
Methods for treating autoimmune disorders, and reagents related thereto
|
AU2002349299A1
(en)
|
2001-12-03 |
2003-06-17 |
Novo Nordisk A/S |
Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
|
WO2003053929A1
(fr)
|
2001-12-21 |
2003-07-03 |
Toray Fine Chemicals Co., Ltd. |
Procede de production de derives de cis-piperidine optiquement actifs
|
US20030148987A1
(en)
|
2001-12-21 |
2003-08-07 |
Morris David J. |
Selective 11beta-HSD inhibitors and methods of use thereof
|
KR101018318B1
(ko)
|
2001-12-21 |
2011-03-04 |
노보 노르디스크 에이/에스 |
Gk 활성제로서의 아미드 유도체
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
AU2002359949A1
(en)
|
2001-12-28 |
2003-07-24 |
Nrl Pharma, Inc. |
Compositions for improving lipid metabolism
|
WO2003057235A2
(en)
|
2002-01-10 |
2003-07-17 |
Imperial College Innovations Ltd |
Modification of feeding behavior
|
US20070197552A1
(en)
|
2002-01-11 |
2007-08-23 |
Novo Nordisk A/S |
Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
|
AU2003201274A1
(en)
|
2002-01-11 |
2003-07-24 |
Novo Nordisk A/S |
Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes
|
MXPA04006997A
(es)
|
2002-01-16 |
2004-12-07 |
Boehringer Ingelheim Pharma |
Comprimido farmaceutico de dos capas que comprende telmisartan y un diuretico y su preparacion.
|
BR0307006A
(pt)
|
2002-01-18 |
2004-11-03 |
Pfizer Prod Inc |
Intermediários para preparar inibidores de glicogênio fosforilase
|
EP2543385A1
(en)
|
2002-01-21 |
2013-01-09 |
NRL Pharma, Inc. |
Novel analgesics
|
EP1333033A1
(en)
|
2002-01-30 |
2003-08-06 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
FAP-activated anti-tumor compounds
|
AU2003207717B9
(en)
|
2002-02-01 |
2009-05-07 |
Merck & Co., Inc. |
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
|
JP2005517690A
(ja)
|
2002-02-01 |
2005-06-16 |
ファイザー・プロダクツ・インク |
固体薬物分散物を含有する即時放出剤形
|
US7610153B2
(en)
|
2002-02-13 |
2009-10-27 |
Virginia Commonwealth University |
Multi-drug titration and evaluation
|
MXPA04008100A
(es)
|
2002-02-21 |
2005-06-17 |
Biovail Lab Int Srl |
Formulaciones de liberacion modificada de al menos una forma de tramadol.
|
EP1338595B1
(en)
|
2002-02-25 |
2006-05-03 |
Eisai Co., Ltd. |
Xanthine derivatives as DPP-IV inhibitors
|
MXPA03000966A
(es)
|
2002-02-28 |
2003-09-04 |
Pfizer Prod Inc |
Agentes antidiabeticos.
|
GB0205170D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
GB0205166D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205175D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205176D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205162D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
CN1307190C
(zh)
|
2002-03-22 |
2007-03-28 |
橘生药品工业株式会社 |
吡喃葡糖基氧代苄基苯衍生物的晶体
|
EP1496052B1
(en)
|
2002-03-26 |
2009-08-05 |
Banyu Pharmaceutical Co., Ltd. |
Novel aminobenzamide derivative
|
JP4298212B2
(ja)
|
2002-03-29 |
2009-07-15 |
大日本印刷株式会社 |
塩酸エピナスチン高融点型結晶の製造法
|
JP2003300977A
(ja)
|
2002-04-10 |
2003-10-21 |
Sumitomo Pharmaceut Co Ltd |
キサンチン誘導体
|
DE10215908B4
(de)
|
2002-04-11 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US6683106B2
(en)
|
2002-04-15 |
2004-01-27 |
Pfizer Inc. |
N-(indole-2-carbonyl)-b-alaninamide crystal forms
|
EP1496982A4
(en)
|
2002-04-16 |
2006-07-19 |
Merck & Co Inc |
SOLID FORMS OF SALTS WITH TYROSINE KINASE EFFECT
|
JPWO2003091213A1
(ja)
|
2002-04-25 |
2005-09-02 |
アステラス製薬株式会社 |
新規なアミド誘導体又はその塩
|
AU2003231517A1
(en)
|
2002-04-26 |
2003-11-10 |
Ajinomoto Co., Inc. |
Preventive/remedy for diabetes
|
RS93604A
(en)
|
2002-04-26 |
2007-02-05 |
F. Hoffmann-La Roche Ag., |
Substituted phenylacetamides and their use as glucokinase activators
|
WO2003094909A2
(en)
|
2002-05-09 |
2003-11-20 |
Enos Pharmaceuticals, Inc. |
Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
|
GB2388594A
(en)
*
|
2002-05-16 |
2003-11-19 |
Bayer Ag |
Imidazo-triazine PDE 4 inhibitors
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
GB0212412D0
(en)
*
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
DE60307628T2
(de)
|
2002-05-31 |
2007-08-09 |
Schering Corporation |
Verfahren zur herstellung von xanthin phosphodiesterase v inhibitoren und deren vorstufen
|
BR0311697A
(pt)
|
2002-06-06 |
2005-03-22 |
Eisai Co Ltd |
Novos derivados condensados de imidazol
|
DE10225635C1
(de)
|
2002-06-07 |
2003-12-24 |
Aventis Pharma Gmbh |
N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
|
ES2199061B1
(es)
|
2002-06-10 |
2005-02-16 |
Laboratorios Vita, S.A. |
Comprimidos bucodispersables y procedimiento para su obtencion.
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
FR2840897B1
(fr)
|
2002-06-14 |
2004-09-10 |
Fournier Lab Sa |
Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique
|
AU2003243921B2
(en)
|
2002-06-27 |
2009-05-07 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
US20040002615A1
(en)
|
2002-06-28 |
2004-01-01 |
Allen David Robert |
Preparation of chiral amino-nitriles
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
JP4374428B2
(ja)
|
2002-07-11 |
2009-12-02 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
尿素置換されたおよびウレタン置換されたアシル尿素、それらの製造方法および医薬としてのそれらの使用方法
|
MXPA05000053A
(es)
|
2002-07-12 |
2005-04-08 |
Aventis Pharma Gmbh |
Benzoilureas heterociclicamente sustituidas, metodo para su produccion y su uso como medicamentos.
|
US20040023981A1
(en)
|
2002-07-24 |
2004-02-05 |
Yu Ren |
Salt forms with tyrosine kinase activity
|
TW200409746A
(en)
|
2002-07-26 |
2004-06-16 |
Theravance Inc |
Crystalline β2 adrenergic receptor agonist
|
AU2003254481A1
(en)
|
2002-07-27 |
2004-02-16 |
Astrazeneca Ab |
Chemical compounds
|
TWI254635B
(en)
|
2002-08-05 |
2006-05-11 |
Yamanouchi Pharma Co Ltd |
Azulene derivative and salt thereof
|
CA2494179C
(en)
|
2002-08-08 |
2012-04-24 |
Kissei Pharmaceutical Co., Ltd. |
Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
|
TWI274055B
(en)
|
2002-08-09 |
2007-02-21 |
Taisho Pharmaceutical Co Ltd |
Aryl-5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same
|
TW200404796A
(en)
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
EP1532149B9
(de)
*
|
2002-08-21 |
2011-04-20 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
8-[3-amino-piperidin-1-yl] -xanthine, deren herstellung und deren verwendung als arzneimittel
|
DE10238243A1
(de)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
US7569574B2
(en)
*
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
JP2004137245A
(ja)
|
2002-08-23 |
2004-05-13 |
Kissei Pharmaceut Co Ltd |
ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
WO2004019958A1
(ja)
|
2002-08-27 |
2004-03-11 |
Kissei Pharmaceutical Co., Ltd. |
ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
|
EP1537880A4
(en)
|
2002-09-11 |
2009-07-01 |
Takeda Pharmaceutical |
PREPARATION FOR PROLONGED RELEASE
|
EP1545474A1
(en)
|
2002-09-16 |
2005-06-29 |
Wyeth |
Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
BR0314655A
(pt)
|
2002-09-26 |
2005-08-02 |
Eisai Co Ltd |
Droga de combinação
|
WO2004050645A1
(en)
|
2002-10-03 |
2004-06-17 |
Novartis Ag |
Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
|
PT1549638E
(pt)
|
2002-10-03 |
2007-12-11 |
Hoffmann La Roche |
Indole-3-cabboxamidas como activantes da glucoquinase
|
DE10246434B4
(de)
|
2002-10-04 |
2005-08-04 |
Aventis Pharma Deutschland Gmbh |
Carboxyalkoxy-substituierte Acyl-carboxyphenyl-harnstoffderivate und ihre Verwendung als Arzneimittel
|
EP1558218A1
(en)
|
2002-10-08 |
2005-08-03 |
Ranbaxy Laboratories Limited |
Gabapentin tablets and methods for their preparation
|
WO2004033455A2
(en)
|
2002-10-08 |
2004-04-22 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
US20040122048A1
(en)
|
2002-10-11 |
2004-06-24 |
Wyeth Holdings Corporation |
Stabilized pharmaceutical composition containing basic excipients
|
CA2501611A1
(en)
|
2002-10-11 |
2004-04-22 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
|
US6861526B2
(en)
|
2002-10-16 |
2005-03-01 |
Pfizer Inc. |
Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
|
NZ538897A
(en)
|
2002-10-18 |
2007-02-23 |
Merck & Co Inc |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
JP2004161749A
(ja)
|
2002-10-24 |
2004-06-10 |
Toray Fine Chemicals Co Ltd |
光学活性含窒素化合物の製造方法
|
KR20050059294A
(ko)
|
2002-10-24 |
2005-06-17 |
스테릭스 리미티드 |
11-베타-하이드록시 스테로이드 데하이드로게나제 형태 1및 형태 2의 억제제
|
JP2006507359A
(ja)
|
2002-10-28 |
2006-03-02 |
ノボ・ノルデイスク・エー/エス |
心循環器疾患の治療のためのグリコーゲンホスホリラーゼ阻害剤の使用
|
WO2004048379A1
(ja)
|
2002-11-01 |
2004-06-10 |
Sumitomo Pharmaceuticals Co., Ltd. |
キサンチン化合物
|
AU2003274462A1
(en)
|
2002-11-07 |
2004-06-07 |
Pfizer Products Inc. |
N-(indole-2-carbonyl) amides as anti-diabetic agents
|
BR0315796A
(pt)
|
2002-11-07 |
2005-09-13 |
Merck & Co Inc |
Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero
|
US20060058315A1
(en)
|
2002-11-07 |
2006-03-16 |
Astrazeneca Ab |
2-Oxo-ethanesulfonamide derivates
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
DE10254304A1
(de)
*
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
UY28103A1
(es)
*
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
US7109192B2
(en)
*
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
JP4651934B2
(ja)
|
2002-12-04 |
2011-03-16 |
キッセイ薬品工業株式会社 |
ベンジルフェノール誘導体、それを含有する医薬組成物およびその医薬用途
|
PT1572196E
(pt)
|
2002-12-10 |
2008-11-20 |
Novartis Ag |
Combinação de um inibidor da dpp-iv e um composto ppar alfa
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
PE20040801A1
(es)
|
2002-12-12 |
2004-11-25 |
Hoffmann La Roche |
Derivados de pirazina y piridina 5-sustituidos como activadores de glucoquinasa
|
JP2004196702A
(ja)
|
2002-12-18 |
2004-07-15 |
Yamanouchi Pharmaceut Co Ltd |
新規なアミド誘導体又はその塩
|
US20040152720A1
(en)
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
DE10351663A1
(de)
|
2002-12-20 |
2004-07-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
JP4679155B2
(ja)
|
2002-12-25 |
2011-04-27 |
キッセイ薬品工業株式会社 |
含窒素複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
WO2004063194A1
(en)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Heteroaryl compounds
|
ES2362656T3
(es)
|
2003-01-06 |
2011-07-11 |
Eli Lilly And Company |
Arilciclopropilacetamidas sustituidas como activadores de glucoquinasa.
|
US20040224886A1
(en)
|
2003-01-08 |
2004-11-11 |
Chiron Corporation |
Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins
|
ATE374766T1
(de)
|
2003-01-14 |
2007-10-15 |
Arena Pharm Inc |
1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
|
DE10335027A1
(de)
*
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
DE10302452B4
(de)
|
2003-01-23 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
US7262196B2
(en)
|
2003-02-11 |
2007-08-28 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
ATE517887T1
(de)
|
2003-02-13 |
2011-08-15 |
Msd Kk |
Neue 2-pyridincarbonsäureamidderivate
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
DE10306502B4
(de)
|
2003-02-17 |
2005-03-17 |
Aventis Pharma Deutschland Gmbh |
Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
|
JP2004250336A
(ja)
|
2003-02-18 |
2004-09-09 |
Kao Corp |
コーティング錠及び糖衣錠の製造法
|
MXPA05009059A
(es)
|
2003-02-26 |
2005-10-19 |
Banyu Pharma Co Ltd |
Derivados de heteroarilcarbamoilbenceno.
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
US7442387B2
(en)
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
DE10309929B4
(de)
|
2003-03-07 |
2006-02-23 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
|
JP2006519852A
(ja)
|
2003-03-12 |
2006-08-31 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ |
弱塩基の塩
|
WO2004080990A1
(ja)
|
2003-03-14 |
2004-09-23 |
Astellas Pharma Inc. |
C-グリコシド誘導体又はその塩
|
NZ541516A
(en)
|
2003-03-18 |
2008-05-30 |
Novartis Ag |
Compositions comprising fatty acids and amino acids
|
JP2004300102A
(ja)
|
2003-03-31 |
2004-10-28 |
Kissei Pharmaceut Co Ltd |
縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
JPWO2004089967A1
(ja)
|
2003-04-01 |
2006-07-06 |
大正製薬株式会社 |
ヘテロアリール5−チオ−β−D−グルコピラノシド誘導体及びそれを含有する糖尿病治療薬
|
ES2528669T3
(es)
|
2003-04-08 |
2015-02-11 |
Progenics Pharmaceuticals, Inc. |
Formulaciones farmacéuticas que contienen metilnaltrexona
|
ES2338656T3
(es)
|
2003-04-11 |
2010-05-11 |
High Point Pharmaceuticals, Llc |
Uso farmaceutico de 1,2,4-triazoles fusionados.
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
WO2004089367A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
ATE467616T1
(de)
|
2003-04-11 |
2010-05-15 |
High Point Pharmaceuticals Llc |
Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
|
MXPA05011176A
(es)
|
2003-04-17 |
2005-12-14 |
Pfizer Prod Inc |
Derivados de carboxamida como agentes antidiabeticos.
|
WO2004096806A1
(ja)
|
2003-04-30 |
2004-11-11 |
Sumitomo Pharmaceuticals Co. Ltd. |
縮合イミダゾール誘導体
|
BRPI0409952A
(pt)
|
2003-04-30 |
2006-04-25 |
Pfizer Prod Inc |
agentes anti-diabéticos
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
AU2003902263A0
(en)
|
2003-05-12 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Monosaccharide compounds
|
WO2004104001A2
(en)
|
2003-05-21 |
2004-12-02 |
Prosidion Limited |
Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
|
WO2004103980A1
(en)
|
2003-05-21 |
2004-12-02 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
|
TW200510277A
(en)
|
2003-05-27 |
2005-03-16 |
Theravance Inc |
Crystalline form of β2-adrenergic receptor agonist
|
FR2855521B1
(fr)
|
2003-05-28 |
2005-08-05 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
|
ATE476425T1
(de)
|
2003-05-29 |
2010-08-15 |
Merck Sharp & Dohme |
Triazolderivate als inhibitoren von 11-beta- hydroxysteroid-dehydrogenase-1
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
DE10327439A1
(de)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
US7566707B2
(en)
*
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
WO2004113345A1
(ja)
|
2003-06-20 |
2004-12-29 |
Japan Tobacco Inc. |
縮合ピロール化合物及びその医薬用途
|
JP4708187B2
(ja)
|
2003-06-20 |
2011-06-22 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体、それを含有する医薬組成物及びその製造中間体
|
ES2355105T3
(es)
|
2003-06-20 |
2011-03-22 |
F. Hoffmann-La Roche Ag |
Pirido(2,1-a)isoquinolina como inhibidores de la dpp-iv.
|
RU2339636C2
(ru)
|
2003-06-20 |
2008-11-27 |
Ф.Хоффманн-Ля Рош Аг |
Гексагидропиридоизохинолины в качестве ингибиторов дипептидилпептидазы iv (dpp-iv)
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
WO2004113310A1
(en)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
|
US7364755B2
(en)
|
2003-07-07 |
2008-04-29 |
Synthon Ip Inc. |
Modified calcium phosphate excipient
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
MXPA06000554A
(es)
|
2003-07-14 |
2006-07-03 |
Arena Pharm Inc |
Derivados arilo y heteroarilo fusionados como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con los mismos.
|
US20050027012A1
(en)
|
2003-07-16 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Tablets containing ambroxol
|
ATE457166T1
(de)
|
2003-07-24 |
2010-02-15 |
Wockhardt Ltd |
Orale zusammensetzungen zur behandlung von diabetes
|
AR048376A1
(es)
|
2003-08-01 |
2006-04-26 |
Janssen Pharmaceutica Nv |
C- glicosidos heterociclos fusionados sustituidos
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
DE10335092B3
(de)
|
2003-08-01 |
2005-02-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
|
EA011515B1
(ru)
|
2003-08-01 |
2009-04-28 |
Янссен Фармацевтика Н.В. |
Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
|
CA2549025A1
(en)
|
2003-08-01 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Substituted indole-o-glucosides
|
SI2896397T2
(sl)
|
2003-08-01 |
2020-12-31 |
Mitsubishi Tanabe Pharma Corporation |
Nove spojine z inhibicijsko aktivnostjo proti od natrija odvisnemu glukoznemu transporterju
|
EA010655B1
(ru)
|
2003-08-01 |
2008-10-30 |
Янссен Фармацевтика Н.В. |
Замещенные индазол-о-глюкозиды
|
RU2355687C2
(ru)
|
2003-08-01 |
2009-05-20 |
Дженелэбс Текнолоджиз, Инк |
Бициклические производные имидазола в качестве средства против вирусов семейства flaviviridae
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
AU2004265299B2
(en)
|
2003-08-07 |
2008-05-01 |
Merck & Co., Inc. |
Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
GB0318464D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
CN102872451A
(zh)
|
2003-08-14 |
2013-01-16 |
诺和诺德医疗保健公司 |
因子vii多肽类的含水液体药物组合物
|
GB0319759D0
(en)
|
2003-08-22 |
2003-09-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0319690D0
(en)
|
2003-08-22 |
2003-09-24 |
Astrazeneca Ab |
Chemical compounds
|
ATE422204T1
(de)
|
2003-08-26 |
2009-02-15 |
Boehringer Ingelheim Int |
Glucopyranosyloxy-pyrazole, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
WO2005020985A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
|
WO2005020986A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
|
WO2005023179A2
(en)
|
2003-08-29 |
2005-03-17 |
Aton Pharma, Inc. |
Combination methods of treating cancer
|
GB0320422D0
(en)
|
2003-08-30 |
2003-10-01 |
Astrazeneca Ab |
Chemical compounds
|
US7790734B2
(en)
|
2003-09-08 |
2010-09-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
ATE534404T1
(de)
|
2003-10-03 |
2011-12-15 |
Takeda Pharmaceutical |
Dipeptidylpeptidase-iv-inhibitoren zur behandlung von diabetes-patienten mit sekundärversagen durch sulfonylharnstoffe
|
US7284625B2
(en)
|
2003-10-22 |
2007-10-23 |
Kirk Jones |
Quick connect assembly for ATV implements
|
WO2005042513A1
(en)
|
2003-10-23 |
2005-05-12 |
Sterix Limited |
Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
|
US20050091394A1
(en)
|
2003-10-27 |
2005-04-28 |
Schneider Automation Inc. |
Software configurable dual cable redundant Ethernet or bus configuration
|
US7246174B2
(en)
|
2003-10-28 |
2007-07-17 |
Nacon Consulting, Llc |
Method and system for accessing and managing virtual machines
|
BR0304443B1
(pt)
|
2003-10-28 |
2012-08-21 |
|
processo para obtenção de concentrados de titánio com elevado teor de tio2 e baixo teor de radionuclìdeos a partir de concentrados mecánicos de anatásio.
|
WO2005044192A2
(en)
|
2003-10-28 |
2005-05-19 |
Amgen Inc. |
Triazole compounds and uses related thereto
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
GB0325745D0
(en)
|
2003-11-05 |
2003-12-10 |
Astrazeneca Ab |
Chemical compounds
|
GB0326029D0
(en)
|
2003-11-07 |
2003-12-10 |
Astrazeneca Ab |
Chemical compounds
|
US7107714B2
(en)
|
2003-11-10 |
2006-09-19 |
Marketing Displays, Inc. |
Portable snap-fit sign stand
|
KR20140089408A
(ko)
*
|
2003-11-17 |
2014-07-14 |
노파르티스 아게 |
디펩티딜 펩티다제 ⅳ 억제제의 용도
|
JP2005170939A
(ja)
|
2003-11-20 |
2005-06-30 |
Takeda Chem Ind Ltd |
糖尿病の予防・治療剤
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
DE10355304A1
(de)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
GB0327760D0
(en)
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
GB0327761D0
(en)
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
US20070219178A1
(en)
*
|
2003-12-04 |
2007-09-20 |
Eisai Co., Ltd. |
Preventive or therapeutic agents for multiple sclerosis
|
GB0328178D0
(en)
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Compounds
|
US7217711B2
(en)
*
|
2003-12-17 |
2007-05-15 |
Boehringer Ingelheim International Gmbh |
Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
RU2381224C2
(ru)
*
|
2003-12-18 |
2010-02-10 |
Тиботек Фармасьютикалз Лтд. |
Пиперидинаминобензимидазольные производные как ингибиторы репликации респираторного синцитиального вируса
|
OA13344A
(en)
|
2003-12-19 |
2007-04-13 |
Pfizer |
Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD-1) for the treatment of diabetes and obesity.
|
US7365075B2
(en)
|
2003-12-22 |
2008-04-29 |
Amgen Inc. |
Aryl sulfonamide compounds and uses related thereto
|
DE10361133A1
(de)
|
2003-12-22 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Glucopyranosyloxy-substituierte Aromaten, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
DE10360835A1
(de)
*
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
CN1898235A
(zh)
|
2003-12-24 |
2007-01-17 |
普罗西迪恩有限公司 |
作为gpcr受体激动剂的杂环衍生物
|
US7728025B2
(en)
|
2003-12-29 |
2010-06-01 |
Banyu Pharmaceutical Co., Ltd. |
2-heteroaryl-substituted benzimidazole derivative
|
EP1711184B1
(en)
|
2004-01-06 |
2007-07-18 |
Janssen Pharmaceutica N.V. |
(3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
|
BRPI0506662B8
(pt)
|
2004-01-06 |
2021-05-25 |
Novo Nordisk As |
compostos ativadores de glucoquinase
|
JP4994043B2
(ja)
|
2004-01-21 |
2012-08-08 |
エランコ・アニマル・ヘルス・アイルランド・リミテッド |
ミトラタピデ経口用溶液
|
CA2553345C
(en)
|
2004-01-26 |
2011-11-15 |
Merck & Co., Inc. |
Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
|
DE102004004971B3
(de)
|
2004-01-31 |
2005-09-15 |
Aventis Pharma Deutschland Gmbh |
Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel
|
DE102004004972B3
(de)
|
2004-01-31 |
2005-09-15 |
Aventis Pharma Deutschland Gmbh |
Heterocyclisch substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2554522A1
(en)
|
2004-01-31 |
2005-08-11 |
Sanofi-Aventis Deutschland Gmbh |
7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
|
US20050239853A1
(en)
|
2004-02-04 |
2005-10-27 |
Tjeerd Barf |
New compounds
|
JP2005247834A
(ja)
|
2004-02-04 |
2005-09-15 |
Taisho Pharmaceut Co Ltd |
ナトリウム依存性グルコース供輸送体2の活性阻害剤
|
SE0400234D0
(sv)
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New compounds, methods for their preparation and use thereof
|
PL1758905T3
(pl)
|
2004-02-18 |
2009-10-30 |
Boehringer Ingelheim Int |
8-[3-Aminopiperydyn-1-ylo]-ksantyna, jej wytwarzanie i jej zastosowanie jako inhibitora DPP-IV
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
EP1718625A1
(en)
|
2004-02-18 |
2006-11-08 |
AstraZeneca AB |
Compounds
|
KR20070007103A
(ko)
|
2004-02-18 |
2007-01-12 |
아스트라제네카 아베 |
벤즈아미드 유도체 및 이의 글루코키나아제 활성화제로서의용도
|
DE102004019540A1
(de)
|
2004-04-22 |
2005-11-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
WO2005085237A1
(ja)
|
2004-03-04 |
2005-09-15 |
Kissei Pharmaceutical Co., Ltd. |
縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
US7375113B2
(en)
|
2004-03-04 |
2008-05-20 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
|
WO2005085265A1
(ja)
|
2004-03-04 |
2005-09-15 |
Kissei Pharmaceutical Co., Ltd. |
縮合ヘテロ環誘導体、それを含有する医薬組成物およびその医薬用途
|
EP1593671A1
(en)
|
2004-03-05 |
2005-11-09 |
Graffinity Pharmaceuticals AG |
DPP-IV inhibitors
|
WO2005085194A2
(en)
|
2004-03-08 |
2005-09-15 |
Prosidion Limited |
Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
|
JP2007527904A
(ja)
|
2004-03-08 |
2007-10-04 |
プロシディオン・リミテッド |
グリコーゲンホスホリラーゼ阻害剤としてのピロロピリジン−2−カルボン酸ヒドラジド化合物
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
GEP20094679B
(en)
|
2004-03-15 |
2009-05-10 |
Takeda Pharmaceuticals Co |
Dipeptidyl peptidase inhibitors
|
EP2295422A3
(de)
|
2004-03-16 |
2012-01-04 |
Boehringer Ingelheim International GmbH |
Glucopyranosylsubstituierte Benzolderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
EP1577306A1
(de)
|
2004-03-17 |
2005-09-21 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
|
JPWO2005090332A1
(ja)
|
2004-03-23 |
2008-01-31 |
萬有製薬株式会社 |
置換キナゾリン又はピリドピリミジン誘導体
|
US7354938B2
(en)
|
2004-03-23 |
2008-04-08 |
Amgen Inc. |
Pyrazole compounds and uses related thereto
|
US20080255216A1
(en)
|
2004-03-29 |
2008-10-16 |
Aster Susan D |
Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
|
TW200602335A
(en)
|
2004-03-31 |
2006-01-16 |
Kissei Pharmaceutical |
Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
|
EP1731524A4
(en)
|
2004-03-31 |
2009-05-20 |
Kissei Pharmaceutical |
PHENOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE, AND ITS MEDICINAL USE
|
WO2005095372A1
(ja)
|
2004-03-31 |
2005-10-13 |
Kissei Pharmaceutical Co., Ltd. |
ナフタレン誘導体、それを含有する医薬組成物及びその医薬用途
|
BRPI0509543A
(pt)
|
2004-04-02 |
2007-09-18 |
Novartis Ag |
derivados de tiazolopiridina, condições farmacêuticas que contêm os mesmos e métodos para tratar condições mediadas por glucocinase
|
ATE524479T1
(de)
|
2004-04-02 |
2011-09-15 |
Novartis Ag |
Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
|
JP2007261945A
(ja)
|
2004-04-07 |
2007-10-11 |
Taisho Pharmaceut Co Ltd |
チアゾール誘導体
|
US7179809B2
(en)
*
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
EP1740589A1
(de)
|
2004-04-10 |
2007-01-10 |
Boehringer Ingelheim International GmbH |
Neue 2-amino-imidazo[4,5-d]pyridazin-4-one und 2-amino-imidazo[4,5-c]pyridin-4-one, deren herstellung und deren verwendung als arzneimittel
|
AU2005243732A1
(en)
|
2004-04-14 |
2005-11-24 |
Amgen, Inc. |
Aryl sulfones and uses related thereto
|
GB0408771D0
(en)
|
2004-04-20 |
2004-05-26 |
Sterix Ltd |
Compound
|
MXPA06012143A
(es)
|
2004-04-20 |
2007-05-15 |
Amgen Inc |
Arilsulfonamidas y usos relacionados con las mismas.
|
NZ550567A
(en)
|
2004-04-21 |
2010-07-30 |
Prosidion Ltd |
Tri(cyclo) substituted amide compounds
|
US20050239778A1
(en)
|
2004-04-22 |
2005-10-27 |
Boehringer Ingelheim International Gmbh |
Novel medicament combinations for the treatment of respiratory diseases
|
US20050244502A1
(en)
|
2004-04-28 |
2005-11-03 |
Mathias Neil R |
Composition for enhancing absorption of a drug and method
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
US20050245532A1
(en)
|
2004-04-29 |
2005-11-03 |
Hoff Ethan D |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
|
US20050261302A1
(en)
|
2004-04-29 |
2005-11-24 |
Hoff Ethan D |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
|
US20050245533A1
(en)
|
2004-04-29 |
2005-11-03 |
Hoff Ethan D |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenaseType 1 enzyme and their therapeutic application
|
US20050245534A1
(en)
|
2004-04-29 |
2005-11-03 |
Link James T |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
KR20070005738A
(ko)
*
|
2004-05-03 |
2007-01-10 |
오메가 바이오 파마(아이.피.3) 리미티드 |
콜레스테롤 과잉혈증 및 당뇨병의 합병증을 치료하기 위한시스테아민
|
WO2005108359A1
(en)
|
2004-05-06 |
2005-11-17 |
Pfizer Inc. |
Novel compounds of proline and morpholine derivatives
|
TWI350168B
(en)
|
2004-05-07 |
2011-10-11 |
Incyte Corp |
Amido compounds and their use as pharmaceuticals
|
NZ551077A
(en)
|
2004-05-07 |
2009-05-31 |
Janssen Pharmaceutica Nv |
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
ATE397586T1
(de)
|
2004-05-07 |
2008-06-15 |
Janssen Pharmaceutica Nv |
Adamantyl pyrrolidin-2-on-derivate als 11-beta hydroxysteroid dehydrogenas inhibitoren
|
US7439370B2
(en)
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
RS51106B
(sr)
|
2004-05-12 |
2010-10-31 |
Pfizer Products Inc. |
Derivati prolina i njihova upotreba kao inhibitora dipeptidil peptidaze iv
|
DE102004024454A1
(de)
|
2004-05-14 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
PE20060315A1
(es)
|
2004-05-24 |
2006-05-15 |
Irm Llc |
Compuestos de tiazol como moduladores de ppar
|
EA014419B1
(ru)
|
2004-05-24 |
2010-12-30 |
Эмджен Инк. |
5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
|
TWI415635B
(zh)
|
2004-05-28 |
2013-11-21 |
必治妥施貴寶公司 |
加衣錠片調製物及製備彼之方法
|
MXPA06014079A
(es)
|
2004-06-01 |
2007-02-15 |
Ares Trading Sa |
Metodo para estabilizar proteinas.
|
EP1756740A1
(en)
|
2004-06-03 |
2007-02-28 |
Pfizer Products Inc. |
Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof
|
WO2005117861A1
(en)
|
2004-06-04 |
2005-12-15 |
Novartis Ag |
Use of organic compounds
|
TW200600086A
(en)
|
2004-06-05 |
2006-01-01 |
Astrazeneca Ab |
Chemical compound
|
EP1604989A1
(en)
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
WO2005120576A2
(en)
*
|
2004-06-09 |
2005-12-22 |
Yasoo Health |
Composition and method for improving pancreatic islet cell survival
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
CN101001850A
(zh)
|
2004-06-24 |
2007-07-18 |
因塞特公司 |
酰胺基化合物及其作为药物的应用
|
JP2008504278A
(ja)
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
JP2008504275A
(ja)
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
N−置換ピペリジンおよびその医薬としての使用
|
CA2589565A1
(en)
|
2004-06-24 |
2006-01-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
EP1773780A4
(en)
|
2004-06-24 |
2008-01-09 |
Incyte Corp |
AMIDO COMPOUNDS AND USES THEREOF AS PHARMACEUTICAL PRODUCTS
|
PL1763517T3
(pl)
|
2004-06-28 |
2011-10-31 |
Hoffmann La Roche |
Pochodne pirymidyny jako inhibitory 11BETA-HSD1
|
US7393836B2
(en)
|
2004-07-06 |
2008-07-01 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
|
CA2511269A1
(en)
|
2004-07-07 |
2006-01-07 |
F. Hoffmann-La Roche Ag |
Multimarker panel based on p1gf for diabetes type 1 and 2
|
BRPI0513384A
(pt)
|
2004-07-14 |
2008-05-06 |
Novartis Ag |
combinação de inibidores de dpp-iv e compostos que modulam receptores de 5-ht3 e/ou 5-ht4
|
DE102004034690A1
(de)
|
2004-07-17 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Methyliden-D-xylopyranosyl-und Oxo-D-xylopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
JP2008508213A
(ja)
|
2004-07-27 |
2008-03-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
D−グルコピラノシル−フェニル置換環状体、そのような化合物を含有する医薬品、それらの使用及びその製造方法
|
ATE400271T1
(de)
|
2004-07-28 |
2008-07-15 |
Hoffmann La Roche |
Aryl-pyridinderivate als 11-beta-hsd1-hemmer
|
US20060025445A1
(en)
|
2004-08-02 |
2006-02-02 |
Xiang Jason S |
11-Beta HSD1 inhibitors
|
JP2008509146A
(ja)
|
2004-08-06 |
2008-03-27 |
メルク エンド カムパニー インコーポレーテッド |
11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのスルホニル化合物
|
JP2006045156A
(ja)
|
2004-08-06 |
2006-02-16 |
Sumitomo Pharmaceut Co Ltd |
縮合ピラゾール誘導体
|
KR20070050076A
(ko)
|
2004-08-10 |
2007-05-14 |
인사이트 산 디에고 인코포레이티드 |
아미도 화합물 및 약제로서의 이의 용도
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
MX2007001650A
(es)
|
2004-08-12 |
2007-07-13 |
Prosidion Ltd |
Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
|
GB0418058D0
(en)
|
2004-08-12 |
2004-09-15 |
Prosidion Ltd |
Fluorination process
|
GB0418046D0
(en)
|
2004-08-12 |
2004-09-15 |
Prosidion Ltd |
Eantioselective process
|
TW200613275A
(en)
|
2004-08-24 |
2006-05-01 |
Recordati Ireland Ltd |
Lercanidipine salts
|
EP1782832A4
(en)
|
2004-08-26 |
2009-08-26 |
Takeda Pharmaceutical |
MEANS FOR THE TREATMENT OF DIABETES
|
DE602005018509D1
(de)
|
2004-08-30 |
2010-02-04 |
Janssen Pharmaceutica Nv |
N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer
|
ATE445600T1
(de)
|
2004-08-30 |
2009-10-15 |
Janssen Pharmaceutica Nv |
Derivate von tricyclischem lactam als 11-beta- hydroxysteroid-dehydrogenase-inhibitoren
|
DE102004043944A1
(de)
*
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
WO2006030805A1
(ja)
|
2004-09-16 |
2006-03-23 |
Astellas Pharma Inc. |
トリアゾール誘導体またはその塩
|
JP4671648B2
(ja)
|
2004-09-17 |
2011-04-20 |
株式会社ソニー・コンピュータエンタテインメント |
中継器、エンタテインメント装置、通信システム、通信方法、及びプログラム
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
AR051446A1
(es)
|
2004-09-23 |
2007-01-17 |
Bristol Myers Squibb Co |
Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
|
AU2005289881A1
(en)
|
2004-09-23 |
2006-04-06 |
Amgen Inc. |
Substituted sulfonamidopropionamides and methods of use
|
JP5046370B2
(ja)
|
2004-09-29 |
2012-10-10 |
キッセイ薬品工業株式会社 |
1−(β−D−グリコピラノシル)−3−置換含窒素ヘテロ環化合物、それを含有する医薬組成物及びその医薬用途
|
DE102004048388A1
(de)
|
2004-10-01 |
2006-04-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
KR100874313B1
(ko)
|
2004-10-04 |
2008-12-18 |
에프. 호프만-라 로슈 아게 |
당뇨병을 치료하기 위한 11-베타 억제제로서의 알킬-피리딘
|
KR20070099527A
(ko)
|
2004-10-08 |
2007-10-09 |
노파르티스 아게 |
유기 화합물의 조합물
|
JP2008515956A
(ja)
|
2004-10-12 |
2008-05-15 |
ノボ ノルディスク アクティーゼルスカブ |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型活性スピロ化合物
|
NZ554515A
(en)
|
2004-10-12 |
2009-12-24 |
Glenmark Pharmaceuticals Sa |
Novel dipeptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and process for their preparation
|
GB0423043D0
(en)
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
GB0423044D0
(en)
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
JP2008517921A
(ja)
|
2004-10-25 |
2008-05-29 |
ノバルティス アクチエンゲゼルシャフト |
Dpp−iv阻害剤、ppar抗糖尿病薬およびメトホルミンの組合わせ剤
|
US7713979B2
(en)
|
2004-10-29 |
2010-05-11 |
Eli Lilly And Company |
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
EP1812407A2
(en)
|
2004-11-02 |
2007-08-01 |
Pfizer, Inc. |
Novel compounds of substituted and unsubstituted adamantyl amides
|
MX2007005289A
(es)
|
2004-11-02 |
2007-07-19 |
Banyu Pharma Co Ltd |
Derivados de bencimidazol ariloxi-sustituido.
|
DE102005013967A1
(de)
|
2004-11-05 |
2006-10-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
US20070249670A1
(en)
|
2004-11-09 |
2007-10-25 |
Smithkline Beecham Corporation |
Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof
|
WO2006051662A1
(ja)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
チアゾール誘導体
|
JP2006137678A
(ja)
|
2004-11-10 |
2006-06-01 |
Shionogi & Co Ltd |
インターロイキン−2組成物
|
GEP20125565B
(en)
|
2004-11-10 |
2012-07-10 |
Incyte Corp |
Lactam compounds and their pharmaceutical use
|
US7223786B2
(en)
|
2004-11-15 |
2007-05-29 |
Bristol-Myers Squibb Company |
2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
|
WO2006053274A2
(en)
|
2004-11-15 |
2006-05-18 |
Bristol-Myers Squibb Company |
2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
US7365061B2
(en)
|
2004-11-15 |
2008-04-29 |
Bristol-Myers Squibb Company |
2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
US7226942B2
(en)
|
2004-11-15 |
2007-06-05 |
Bristol-Myers Squibb Company |
2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
EP1824842A4
(en)
|
2004-11-18 |
2009-08-26 |
Incyte Corp |
INHIBITORS OF 11-HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHOD OF USE
|
US7750145B2
(en)
|
2004-11-18 |
2010-07-06 |
Kissei Pharmaceutical Co., Ltd. |
1-substituted-3-β-D-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same
|
GB0425919D0
(en)
|
2004-11-25 |
2004-12-29 |
Prosidion Ltd |
Indole-2-carboxylic acid amides
|
DE602005013275D1
(de)
|
2004-12-02 |
2009-04-23 |
Prosidion Ltd |
Pyrrolopyridin-2-karbonsäureamide
|
US20090298745A1
(en)
|
2004-12-02 |
2009-12-03 |
Gerard Hugh Thomas |
Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
|
ATE400574T1
(de)
|
2004-12-02 |
2008-07-15 |
Prosidion Ltd |
Pyrrolopyridin-2-karbonsäureamid-derivat zur verwendung als inhibitor gegen glykogenphosphorylase
|
WO2006058923A1
(en)
|
2004-12-03 |
2006-06-08 |
Novo Nordisk A/S |
Heteroaromatic glucokinase activators
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
JP2008524162A
(ja)
|
2004-12-16 |
2008-07-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換ベンゼン誘導体、該化合物を含む薬物、その使用及びその製造方法
|
JP2008524244A
(ja)
|
2004-12-17 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
水酸化ステロイド脱水素酵素阻害剤
|
ATE399546T1
(de)
|
2004-12-20 |
2008-07-15 |
Lilly Co Eli |
Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1
|
DE602005008282D1
(de)
|
2004-12-21 |
2008-08-28 |
Lilly Co Eli |
Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1
|
WO2006068199A1
(ja)
|
2004-12-22 |
2006-06-29 |
Mochida Pharmaceutical Co., Ltd. |
代謝的に安定な3-オキシ-1,2,4-トリアゾール誘導体
|
TW200635930A
(en)
|
2004-12-24 |
2006-10-16 |
Dainippon Sumitomo Pharma Co |
Bicyclic pyrrole derivatives
|
KR100760430B1
(ko)
|
2004-12-31 |
2007-10-04 |
한미약품 주식회사 |
당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
|
EP1846363B1
(en)
|
2005-01-05 |
2012-04-25 |
Abbott Laboratories |
Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
US20060148871A1
(en)
|
2005-01-05 |
2006-07-06 |
Rohde Jeffrey J |
Metabolic stabilization of substituted adamantane
|
KR101302627B1
(ko)
|
2005-01-05 |
2013-09-10 |
아비에 인코포레이티드 |
11-베타-하이드록시스테로이드 데하이드로게나제 타입 1 효소의 억제제
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
GT200600008A
(es)
|
2005-01-18 |
2006-08-09 |
|
Formulacion de compresion directa y proceso
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
WO2006080533A1
(ja)
|
2005-01-31 |
2006-08-03 |
Mochida Pharmaceutical Co., Ltd. |
3-アミノ-1,2,4-トリアゾール誘導体
|
US20090124682A1
(en)
|
2005-02-05 |
2009-05-14 |
Alan Martin Birch |
Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity
|
US20100137397A1
(en)
|
2005-02-05 |
2010-06-03 |
Astrazeneca Ab |
Chemical Compounds
|
US7749972B2
(en)
|
2005-02-15 |
2010-07-06 |
Kissei Pharmaceutical Co., Ltd. |
1-substituted-7-(β-D-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
|
AU2006222372B8
(en)
|
2005-03-03 |
2010-04-08 |
F. Hoffmann-La Roche Ag |
1-sulfonyl-piperidine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type II diabetes mellitus
|
WO2006095822A1
(ja)
|
2005-03-11 |
2006-09-14 |
Ono Pharmaceutical Co., Ltd. |
スルホンアミド化合物およびその医薬
|
WO2006097337A2
(en)
|
2005-03-18 |
2006-09-21 |
Onepharm Gmbh |
11β-HYDROXYSTEROID DEHYDROGENASES
|
GB0506133D0
(en)
|
2005-03-24 |
2005-05-04 |
Sterix Ltd |
Compound
|
JPWO2006104280A1
(ja)
|
2005-03-31 |
2008-09-11 |
武田薬品工業株式会社 |
糖尿病の予防・治療剤
|
EP1866298A2
(en)
|
2005-03-31 |
2007-12-19 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
KR100931411B1
(ko)
|
2005-04-05 |
2009-12-10 |
에프. 호프만-라 로슈 아게 |
1h-피라졸 4-카복실아미드, 이의 제조 방법, 및 이의 11베타-하이드록시스테로이드 탈수소효소로서의 용도
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
WO2006113261A2
(en)
|
2005-04-14 |
2006-10-26 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
ES2338041T3
(es)
|
2005-04-15 |
2010-05-03 |
Boehringer Ingelheim International Gmbh |
Derivados de (heteroariloxi-bencil)-benceno sustituidos con glucopiranosilo en calidad de inhibidores de sglt.
|
CA2605778A1
(en)
|
2005-04-20 |
2006-10-26 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
WO2006111169A1
(en)
|
2005-04-21 |
2006-10-26 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
MX2007011453A
(es)
|
2005-04-22 |
2008-02-12 |
Alantos Pharmaceuticals Holding Inc |
Inhibidores de la dipeptidil peptidasa-iv.
|
EP1875862B1
(en)
|
2005-04-25 |
2015-07-15 |
Hitachi, Ltd. |
Inspection equipment employing magnetic resonance
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
EP1884513A4
(en)
|
2005-05-23 |
2010-04-28 |
Japan Tobacco Inc |
PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME
|
US20110059941A1
(en)
|
2005-05-24 |
2011-03-10 |
Peter William Rodney Caulkett |
2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators
|
JP2008545688A
(ja)
|
2005-05-25 |
2008-12-18 |
ワイス |
置換3−シアノキノリン並びにその中間体を合成する方法
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
CA2610361C
(en)
|
2005-06-03 |
2013-11-26 |
Mitsubishi Tanabe Pharma Corporation |
Combination of 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine and a second active agent and use thereof for plasma glucose control
|
US8952176B2
(en)
|
2005-06-07 |
2015-02-10 |
Shionogi & Co., Ltd. |
Heterocyclic compound having type I 11 β hydroxysteroid dehydrogenase inhibitory activity
|
EP1889842A4
(en)
|
2005-06-08 |
2009-07-29 |
Japan Tobacco Inc |
HETEROCYCLIC CONNECTION
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
GT200600218A
(es)
|
2005-06-10 |
2007-03-28 |
|
Formulación y proceso de compresión directa
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
ES2334518T3
(es)
|
2005-06-16 |
2010-03-11 |
Pfizer, Inc. |
Derivados de n-(piridin-2-il)-sulfonamida.
|
US7605289B2
(en)
|
2005-06-17 |
2009-10-20 |
Amgen, Inc. |
Benzamide derivatives and uses related thereto
|
EA016397B1
(ru)
|
2005-06-20 |
2012-04-30 |
Декоуд Дженетикс Ехф. |
Генетические варианты гена tcf7l2 как диагностические маркеры риска возникновения сахарного диабета ii типа
|
EP1901741B1
(en)
|
2005-07-01 |
2015-09-16 |
Merck Sharp & Dohme Corp. |
Process for synthesizing a cetp inhibitor
|
RS51994B
(en)
|
2005-07-05 |
2012-04-30 |
F. Hoffmann-La Roche Ag |
DERIVATI PIRIDAZINA
|
DE602006017373D1
(de)
|
2005-07-08 |
2010-11-18 |
Pfizer Ltd |
Madcam-antikörper
|
US7999114B2
(en)
|
2005-07-08 |
2011-08-16 |
Novo Nordisk A/S |
Dicycloalkylcarbamoyl ureas as glucokinase activators
|
JPWO2007007688A1
(ja)
|
2005-07-08 |
2009-01-29 |
持田製薬株式会社 |
3,5−ジアミノ−1,2,4−トリアゾール誘導体
|
EP1904466A1
(en)
|
2005-07-08 |
2008-04-02 |
Novo Nordisk A/S |
Dicycloalkyl urea glucokinase activators
|
BRPI0622261A2
(pt)
|
2005-07-09 |
2011-08-09 |
Astrazeneca Ab |
composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
|
US20080234273A1
(en)
|
2005-07-09 |
2008-09-25 |
Mckerrecher Darren |
Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
|
WO2007007040A1
(en)
|
2005-07-09 |
2007-01-18 |
Astrazeneca Ab |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
US7514439B2
(en)
|
2005-07-11 |
2009-04-07 |
Mitsubishi Tanabe Pharma Corporation |
Oxime derivative and preparations thereof
|
US7994331B2
(en)
|
2005-07-13 |
2011-08-09 |
Msd K.K. |
Heterocycle-substituted benzimidazole derivative
|
JP4960355B2
(ja)
|
2005-07-14 |
2012-06-27 |
ノボ・ノルデイスク・エー/エス |
ウレア型グルコキナーゼ活性化剤
|
AU2006272922A1
(en)
|
2005-07-22 |
2007-02-01 |
Amgen Inc. |
Aniline sulfonamide derivatives and their uses
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
US20100160286A1
(en)
|
2005-08-09 |
2010-06-24 |
Astrazeneca Uk Limited Ab |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
CN101232873A
(zh)
|
2005-08-11 |
2008-07-30 |
霍夫曼-拉罗奇有限公司 |
含有dpp-iv抑制剂的药物组合物
|
US7622492B2
(en)
|
2005-08-31 |
2009-11-24 |
Hoffmann-La Roche Inc. |
Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
|
EP1760076A1
(en)
|
2005-09-02 |
2007-03-07 |
Ferring B.V. |
FAP Inhibitors
|
RS52110B2
(sr)
|
2005-09-14 |
2018-05-31 |
Takeda Pharmaceuticals Co |
Inhibitori dipeptidil peptidaze za lečenje dijabetesa
|
US20070060528A1
(en)
|
2005-09-14 |
2007-03-15 |
Christopher Ronald J |
Administration of dipeptidyl peptidase inhibitors
|
DE602006006461D1
(de)
|
2005-09-16 |
2009-06-04 |
Arena Pharm Inc |
Stoffwechselmodulatoren und behandlung damit verbundener erkrankungen
|
US8143217B2
(en)
|
2005-09-20 |
2012-03-27 |
Novartis Ag |
Use of DPP-IV inhibitor to reduce hypoglycemic events
|
WO2007038979A1
(en)
|
2005-09-22 |
2007-04-12 |
Swissco Development Ag |
Effervescent metformin composition and tablets and granules made therefrom
|
JOP20180109A1
(ar)
|
2005-09-29 |
2019-01-30 |
Novartis Ag |
تركيبة جديدة
|
RU2008116578A
(ru)
|
2005-09-30 |
2009-11-10 |
Новартис АГ (CH) |
Применение ингибиторов dpp-iv для лечения аутоиммунных заболеваний и отторжения трансплантата
|
AU2006306420A1
(en)
|
2005-10-25 |
2007-05-03 |
Merck Sharp & Dohme Corp. |
Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
|
WO2007052964A1
(en)
|
2005-11-04 |
2007-05-10 |
Ls Cable Ltd. |
Synthesis of mdh-polymer hybrid particles
|
EP1962827A4
(en)
|
2005-12-16 |
2011-02-16 |
Merck Sharp & Dohme |
PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL-PEPTIDASE-4-INHIBITORS WITH METFORMIN
|
WO2007071738A1
(en)
|
2005-12-23 |
2007-06-28 |
Novartis Ag |
Condensed heterocyclic compounds useful as dpp-iv inhibitors
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
CA2635399A1
(en)
|
2006-01-06 |
2007-10-25 |
Novartis Ag |
Use.of vildagliptin for the treatment of diabetes
|
US7745414B2
(en)
|
2006-02-15 |
2010-06-29 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
WO2007099345A1
(en)
|
2006-03-02 |
2007-09-07 |
Betagenon Ab |
Medical use of bmp-2 and/ or bmp-4
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
US8455435B2
(en)
|
2006-04-19 |
2013-06-04 |
Ludwig-Maximilians-Universitat Munchen |
Remedies for ischemia
|
EA015687B1
(ru)
|
2006-05-04 |
2011-10-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Полиморфы
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
ATE534377T1
(de)
|
2006-05-16 |
2011-12-15 |
Gilead Sciences Inc |
Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen
|
KR20070111099A
(ko)
|
2006-05-16 |
2007-11-21 |
영진약품공업주식회사 |
시타글립틴 염산염의 신규 결정형, 이의 제조 방법과 이를포함하는 약학적 조성물
|
WO2007137107A2
(en)
|
2006-05-19 |
2007-11-29 |
Abbott Laboratories |
Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
|
KR100858848B1
(ko)
|
2006-05-23 |
2008-09-17 |
한올제약주식회사 |
메트포르민 서방정
|
WO2007149797A2
(en)
|
2006-06-19 |
2007-12-27 |
Novartis Ag |
Use of organic compounds
|
WO2007148185A2
(en)
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
AT503443B1
(de)
|
2006-06-23 |
2007-10-15 |
Leopold Franzens Uni Innsbruck |
Verfahren zur herstellung einer eisfläche für eissportbahnen
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
EP2057160A1
(en)
|
2006-08-08 |
2009-05-13 |
Boehringer Ingelheim International GmbH |
Pyrrolo [3, 2 -d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
|
EP2054426A1
(en)
|
2006-08-15 |
2009-05-06 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
CA2661293A1
(en)
|
2006-08-17 |
2008-02-21 |
Wellstat Therapeutics Corporation |
Combination treatment for metabolic disorders
|
DE102006042586B4
(de)
|
2006-09-11 |
2014-01-16 |
Betanie B.V. International Trading |
Verfahren zum mikropartikulären Beladen von hochpolymeren Kohlenhydraten mit hydrophoben Wirkflüssigkeiten
|
US7956201B2
(en)
|
2006-11-06 |
2011-06-07 |
Hoffman-La Roche Inc. |
Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one
|
US7879806B2
(en)
|
2006-11-06 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzonitrile derivates, medicaments containing such compounds, their use and process for their manufacture
|
NZ598778A
(en)
|
2006-11-09 |
2013-09-27 |
Boehringer Ingelheim Int |
Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
|
MX2009005935A
(es)
|
2006-12-06 |
2009-06-30 |
Smithkline Beecham Corp |
Compuestos biciclicos y su uso como anti-diabeticos.
|
ES2319596B1
(es)
|
2006-12-22 |
2010-02-08 |
Laboratorios Almirall S.A. |
Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
CL2008000017A1
(es)
|
2007-01-04 |
2008-08-01 |
Prosidion Ltd |
Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
|
CL2008000133A1
(es)
|
2007-01-19 |
2008-05-23 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un compuesto derivado de pirazol-o-glucosido combinado con al menos un segundo agente terapeutico; y uso de la composicion para el tratamiento de diabetes mellitus, cataratas, neuropatia, infarto de miocardio, e
|
EP2124901B1
(en)
|
2007-02-01 |
2017-07-19 |
Takeda Pharmaceutical Company Limited |
Tablet preparation without causing a tableting trouble
|
DE602008003522D1
(de)
|
2007-02-01 |
2010-12-30 |
Takeda Pharmaceutical |
Feste zubereitung mit alogliptin und pioglitazon
|
EP2118051B1
(en)
|
2007-02-06 |
2011-05-04 |
Chelsea Therapeutics, Inc. |
New compounds, methods for their preparation and use thereof
|
CA2681092A1
(en)
|
2007-03-15 |
2008-09-18 |
Nectid, Inc. |
Anti-diabetic combinations comprising a slow release biguanide composition and an immediate release dipeptidyl peptidase iv inhibitor composition
|
KR101361427B1
(ko)
|
2007-04-03 |
2014-02-10 |
미쓰비시 타나베 파마 코퍼레이션 |
디펩티딜 펩티다아제 4 저해 화합물과 감미료와의 병용
|
EP2508141A1
(en)
|
2007-04-16 |
2012-10-10 |
Smith & Nephew, Inc. |
Powered surgical system
|
PE20090696A1
(es)
|
2007-04-20 |
2009-06-20 |
Bristol Myers Squibb Co |
Formas cristalinas de saxagliptina y procesos para preparar las mismas
|
CN101668756A
(zh)
|
2007-05-04 |
2010-03-10 |
百时美施贵宝公司 |
[6,6]和[6,7]-双环gpr119 g蛋白偶合受体激动剂
|
EP2178493B2
(en)
|
2007-07-09 |
2015-12-09 |
Symrise AG |
Stable soluble salts of phenylbenzimidazole sulfonic acid at pH 6.0 to below 6.8
|
NZ583346A
(en)
|
2007-07-19 |
2012-02-24 |
Takeda Pharmaceutical |
Solid preparation comprising alogliptin and metformin hydrochloride
|
PE20090938A1
(es)
|
2007-08-16 |
2009-08-08 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
|
PE20090987A1
(es)
|
2007-08-16 |
2009-08-14 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un derivado de pirazol-o-glucosido
|
PE20090603A1
(es)
|
2007-08-16 |
2009-06-11 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de sglt2 y un inhibidor de dpp iv
|
UY31291A1
(es)
|
2007-08-16 |
2009-03-31 |
|
Composicion farmacéutica que comprende un derivado de pirazol-0-glucosido
|
US20110112069A1
(en)
|
2007-08-17 |
2011-05-12 |
Boehringer Ingelheim International Gmbh |
Purin derivatives for use in the treatment of fab-related diseases
|
US8338450B2
(en)
|
2007-09-21 |
2012-12-25 |
Lupin Limited |
Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
|
EP2215119B1
(en)
|
2007-11-13 |
2012-12-26 |
Evec Inc. |
Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
|
PL2597103T3
(pl)
|
2007-11-16 |
2017-04-28 |
Novo Nordisk A/S |
Stabilne kompozycje farmaceutyczne zawierające liraglutyd i degludec
|
CN101234105A
(zh)
|
2008-01-09 |
2008-08-06 |
北京润德康医药技术有限公司 |
一种含有二甲双胍和维格列汀的药用组合物及其制备方法
|
US20090186086A1
(en)
|
2008-01-17 |
2009-07-23 |
Par Pharmaceutical, Inc. |
Solid multilayer oral dosage forms
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
TW200936136A
(en)
|
2008-01-28 |
2009-09-01 |
Sanofi Aventis |
Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application
|
AU2009210641A1
(en)
|
2008-02-05 |
2009-08-13 |
Merck Sharp & Dohme Corp. |
Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-IV inhibitor
|
CN101959406A
(zh)
|
2008-03-04 |
2011-01-26 |
默沙东公司 |
二甲双胍和二肽基肽酶-ⅳ抑制剂的组合的药物组合物
|
AU2009220615B2
(en)
|
2008-03-05 |
2013-12-19 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
US8551524B2
(en)
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
KR20100134659A
(ko)
|
2008-03-31 |
2010-12-23 |
메타볼렉스, 인코포레이티드 |
옥시메틸렌 아릴 화합물 및 그것의 사용
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
CN101590007A
(zh)
|
2008-05-27 |
2009-12-02 |
北京瑞伊人科技发展有限公司 |
一种盐酸二甲双胍/伏格列波糖降糖口服制剂组合物及其制备
|
PE20100156A1
(es)
|
2008-06-03 |
2010-02-23 |
Boehringer Ingelheim Int |
Tratamiento de nafld
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
KR20200118243A
(ko)
|
2008-08-06 |
2020-10-14 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
MX2011001525A
(es)
|
2008-08-15 |
2011-03-29 |
Boehringer Ingelheim Int |
Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
|
JP2010053576A
(ja)
|
2008-08-27 |
2010-03-11 |
Sumitomo Forestry Co Ltd |
舗装用マット
|
MX2011002558A
(es)
|
2008-09-10 |
2011-04-26 |
Boehringer Ingelheim Int |
Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
|
UY32177A
(es)
|
2008-10-16 |
2010-05-31 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con control glucémico insuficiente a pesar de la terapia con fármaco, oral o no, antidiabético
|
WO2010045656A2
(en)
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
CA2745037C
(en)
|
2008-12-23 |
2020-06-23 |
Boehringer Ingelheim International Gmbh |
Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8(3-(r)-amino-piperidin-1-yl)-xanthine
|
TW201036975A
(en)
|
2009-01-07 |
2010-10-16 |
Boehringer Ingelheim Int |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
|
AR075204A1
(es)
|
2009-01-29 |
2011-03-16 |
Boehringer Ingelheim Int |
Inhibidores de dpp-4 y composiciones farmaceuticas que los comprenden, utiles para tratar enfermedades metabolicas en pacientes pediatricos, particularmente diabetes mellitus tipo 2
|
CN102307577A
(zh)
|
2009-02-13 |
2012-01-04 |
贝林格尔.英格海姆国际有限公司 |
包含sglt2抑制剂、dpp-iv抑制剂和任选的另一种抗糖尿病药的药物组合物及其用途
|
UY32427A
(es)
|
2009-02-13 |
2010-09-30 |
Boheringer Ingelheim Internat Gmbh |
Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
|
US20120094894A1
(en)
|
2009-02-13 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
|
TW201031661A
(en)
|
2009-02-17 |
2010-09-01 |
Targacept Inc |
Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
US8815292B2
(en)
|
2009-04-27 |
2014-08-26 |
Revalesio Corporation |
Compositions and methods for treating insulin resistance and diabetes mellitus
|
MX2011011333A
(es)
|
2009-04-27 |
2011-11-18 |
Revalesio Corp |
Composiciones y metodos para tratar la resistencia a la insulina y la diabetes mellituscampo de la invencion.
|
WO2010140111A1
(en)
|
2009-06-02 |
2010-12-09 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
|
US20120059011A1
(en)
|
2009-06-15 |
2012-03-08 |
Nicholas Birringer |
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
|
AU2010276242B2
(en)
|
2009-07-21 |
2014-05-29 |
Keryx Biopharmaceuticals, Inc. |
Ferric citrate dosage forms
|
ES2942185T3
(es)
|
2009-10-02 |
2023-05-30 |
Boehringer Ingelheim Int |
Composiciones farmacéuticas que comprenden BI-1356 y metformina
|
US10610489B2
(en)
|
2009-10-02 |
2020-04-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
|
JP5446716B2
(ja)
|
2009-10-21 |
2014-03-19 |
大正製薬株式会社 |
アルギニン及びカルニチン含有錠剤の製造方法
|
CN107115530A
(zh)
|
2009-11-27 |
2017-09-01 |
勃林格殷格翰国际有限公司 |
基因型糖尿病患者利用dpp‑iv抑制剂例如利拉利汀的治疗
|
JP2010070576A
(ja)
|
2009-12-28 |
2010-04-02 |
Sato Pharmaceutical Co Ltd |
速溶解性錠剤
|
TWI562775B
(en)
|
2010-03-02 |
2016-12-21 |
Lexicon Pharmaceuticals Inc |
Methods of using inhibitors of sodium-glucose cotransporters 1 and 2
|
EP2547339A1
(en)
|
2010-03-18 |
2013-01-23 |
Boehringer Ingelheim International GmbH |
Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
|
AU2011249722B2
(en)
|
2010-05-05 |
2015-09-17 |
Boehringer Ingelheim International Gmbh |
Combination therapy
|
AR082091A1
(es)
|
2010-05-05 |
2012-11-14 |
Boehringer Ingelheim Int |
Composiciones farmaceuticas que comprenden pioglitazona y linagliptina y procedimiento de preparacion
|
WO2011154496A1
(en)
|
2010-06-09 |
2011-12-15 |
Poxel |
Treatment of type 1 diabetes
|
JP2013533241A
(ja)
|
2010-06-22 |
2013-08-22 |
ティダブリューアイ・ファーマシューティカルズ・インコーポレイテッド |
食物効果が減少した制御放出組成物
|
KR20220025926A
(ko)
|
2010-06-24 |
2022-03-03 |
베링거 인겔하임 인터내셔날 게엠베하 |
당뇨병 요법
|
US20130224296A1
(en)
|
2010-09-03 |
2013-08-29 |
Bristol-Myers Squibb Company |
Drug Formulations Using Water Soluble Antioxidants
|
WO2012039420A1
(ja)
|
2010-09-21 |
2012-03-29 |
国立大学法人九州大学 |
動脈圧反射機能障害に関連した疾患を治療するためのバイオニック動脈圧反射システム
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
WO2012088682A1
(en)
|
2010-12-29 |
2012-07-05 |
Shanghai Fochon Pharmaceutical Co Ltd. |
2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
|
JP2014504639A
(ja)
|
2011-02-01 |
2014-02-24 |
ブリストル−マイヤーズ スクイブ カンパニー |
アミン化合物を含む医薬製剤
|
UY33937A
(es)
|
2011-03-07 |
2012-09-28 |
Boehringer Ingelheim Int |
Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
|
CA2835332C
(en)
|
2011-05-10 |
2019-03-26 |
Sandoz Ag |
Polymorph of linagliptin benzoate
|
KR101985384B1
(ko)
|
2011-07-15 |
2019-06-03 |
베링거 인겔하임 인터내셔날 게엠베하 |
치환된 퀴나졸린, 이의 제조 및 약제학적 조성물에서의 이의 용도
|
US20130172244A1
(en)
|
2011-12-29 |
2013-07-04 |
Thomas Klein |
Subcutaneous therapeutic use of dpp-4 inhibitor
|
US9139802B2
(en)
|
2012-01-04 |
2015-09-22 |
The Procter & Gamble Company |
Active containing fibrous structures with multiple regions
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
US20130303554A1
(en)
|
2012-05-14 |
2013-11-14 |
Boehringer Ingelheim International Gmbh |
Use of a dpp-4 inhibitor in sirs and/or sepsis
|
EP2849755A1
(en)
|
2012-05-14 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
|
WO2013174768A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of autoimmune diabetes, particularly lada
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
EP2854824A1
(en)
|
2012-05-25 |
2015-04-08 |
Boehringer Ingelheim International GmbH |
Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor
|
WO2013179307A2
(en)
|
2012-05-29 |
2013-12-05 |
Mylan Laboratories Limited |
Stabilized pharmaceutical compositions of saxagliptin
|
CA2882771C
(en)
|
2012-08-24 |
2021-02-23 |
Novartis Ag |
Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling
|
US20140100292A1
(en)
|
2012-10-09 |
2014-04-10 |
Boehringer Ingelheim International Gmbh |
Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets
|
EP2908806A1
(en)
|
2012-10-09 |
2015-08-26 |
Boehringer Ingelheim International GmbH |
Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets
|
US9050302B2
(en)
|
2013-03-01 |
2015-06-09 |
Jazz Pharmaceuticals Ireland Limited |
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
|
BR112015020209A2
(pt)
|
2013-03-15 |
2017-07-18 |
Boehringer Ingelheim Int |
uso de linagliptina em terapia antidiabética de proteção cardíaca e renal
|
PL2986304T3
(pl)
|
2013-04-18 |
2022-05-02 |
Boehringer Ingelheim International Gmbh |
Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
|
EP2996724A1
(en)
|
2013-05-17 |
2016-03-23 |
Boehringer Ingelheim International GmbH |
Combination of a dpp-4 inhibitor and an alpha-glucosidase inhibitor
|
CA2914791A1
(en)
|
2013-06-14 |
2014-12-18 |
Boehringer Ingelheim International Gmbh |
Dpp-4 inhibitors for treating diabetes and its complications
|
JP6615109B2
(ja)
|
2014-02-28 |
2019-12-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Dpp−4阻害薬の医学的使用
|
CN104130258B
(zh)
|
2014-08-13 |
2016-06-01 |
广东东阳光药业有限公司 |
一种二聚体的转化方法
|
WO2016059219A1
(en)
|
2014-10-17 |
2016-04-21 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
CA3022202A1
(en)
|
2016-06-10 |
2017-12-14 |
Boehringer Ingelheim International Gmbh |
Combinations of linagliptin and metformin
|
CN112423761A
(zh)
|
2018-07-17 |
2021-02-26 |
勃林格殷格翰国际有限公司 |
心脏安全的抗糖尿病疗法
|